Subscribe
The Daily Grind Video
CLOSE

The flesh-eating drug dubbed the “poor man’s heroin” first identified in Russia has finally made it’s way to western Mexico.

After reports that two sisters used the drug called Krokodil in Ohio, we’re now learning of a 17-year-old Houston, Texas teenager who injected the drug while on a trip south of the border to visit relatives.

Now, the unidentified teen is suffering from rotting genitals, as this is the area she injected the drugs into.

But doctors first thought that the 17-year-old was suffering from a sexually transmitted disease. However, they soon found out that she had been a user of the aggressive street drug.

‘”It wasn’t sexually transmitted. She said she’d been using Krokodil for the last two months,” José Sotero Ruiz Hernández of Mexico’s National Institute of Migration told local paper El Periodico Correo.

“The young woman who used this drug had an infection that had rotted her genitals.”

The victim has not been named and her status is unknown as she never returned to the clinic for a second check in.

Mexico, however, isn’t so quick to believe the teen obtained the drugs in their country. The head of the council on addictions in the western state of Jalisco, Dr. Enrico Sotelo, said young woman is a resident of Houston, Texas and not Mexico and that she acquired this problem with Krokodil in Houston, not in Puerto Vallarta.

In fact, Sotelo said a survey of rehab centers and clinics in Jalisco had revealed there were no other local cases.

He said so far, Mexico has detected only two probable cases, the woman in Puerto Vallarta and another person in the border state of Baja California. Diagnosis is usually based on the tell-tale lesions, because the body quickly metabolizes the drug’s psychoactive agent, desomorphine.

Houston or Mexico, the truth is the flesh-eating drug, concocted by cooking the prescription painkiller codeine along with gasoline, iodine, phosphorus and other chemicals, is spreading.

And spreading fast…

SOURCE: Daily Mail | VIDEO SOURCE: News, Inc.